Stoke Therapeutics, Inc.
USD27.62
-0.06 (-0.23%)
CEO
Ian F. Smith
IPO Date
2019-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.66
Prev. Close
$27.68
Day Low
$27.23
Day High
$27.93
52W Low
$12.25
52W High
$40.22
Market Cap
$1.72B
Volume
0.13M
| 29,555 |
| $28.80 |
| 17 Jul 2026 | Harrison Seth Loring | director | G-Gift | Disposed | 14,777 | $26.53 |
| 17 Jul 2026 | Harrison Seth Loring | director | G-Gift | Acquired | 14,777 | $26.53 |
| 17 Jul 2026 | Harrison Seth Loring | director | G-Gift | Disposed | 11,650 | $40.37 |
| 17 Jul 2026 | Harrison Seth Loring | director | G-Gift | Acquired | 11,650 | $40.37 |
| 17 Jul 2026 | Harrison Seth Loring | director | G-Gift | Disposed | 21,000 | $12.96 |
| 17 Jul 2026 | Harrison Seth Loring | director | G-Gift | Acquired | 21,000 | $12.96 |
| 17 Jul 2026 | Harrison Seth Loring | director | G-Gift | Disposed | 19,441 | $12.46 |
| 17 Jul 2026 | Harrison Seth Loring | director | G-Gift | Acquired | 19,441 | $12.46 |